ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 2614

Risk of New Onset of Immune-Mediated Diseases After Sars-Cov-2 Infection: A Systematic Review and Meta-Analysis

Ana Milena Gil1, Julián Barahona-Correa2, Jorge Bruce Flórez-Suárez3, Daniel Fernández-Ávila4 and Zulma Cucunubá1, 1Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogotá, Colombia, 2Division of Rheumatology, Pontificia Universidad Javeriana - Hospital Universitario San Ignacio, Bogotá, Colombia, 3Department of Immunology, Universidad Nacional de Colombia, Bogotá, Colombia, 45Hospital San Ignacio, Colombia, BOGOTA, Colombia

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, COVID-19, Infection, meta-analysis

Session Information

Date: Monday, November 18, 2024

Title: Abstracts: Infection-related Rheumatic Disease

Session Type: Abstract Session

Session Time: 3:00PM-4:30PM

Background/Purpose: The association between SARS-CoV-2 infection and the new onset of immune-mediated diseases is a topic of interest given the conflicting evidence available. This systematic review and meta-analysis aims to estimate the risk of immune-mediated diseases following SARS-CoV-2 infection.

Methods: Analytical observational studies reporting immune-mediated diseases after confirmed SARS-CoV-2 infection, compared to individuals without infection history, were included. Thirty-nine immune-mediated diseases were defined as outcomes of interest. Studies that included diagnosis within the first 30 days post-infection were excluded. Searches were conducted on June 27th, 2023, in PubMed, EMBASE, CINAHL, Web of Science, and Europe PMC. Two reviewers independently conducted selection, data extraction, and quality assessment. Relative risks were pooled using a random-effects model and the Mantel-Haenszel method. PROSPERO (CRD42023472446).

Results: Eight studies met the eligibility criteria. Meta-analyses were conducted for 12 outcomes of interest using data from six studies. The SARS-CoV-2 exposed group exhibited significantly higher risks for 11 conditions: Behçet’s disease, spondyloarthritis, systemic sclerosis, systemic lupus erythematosus, polymyalgia rheumatica, psoriasis, rheumatoid arthritis, Sjögren’s syndrome, type 1 diabetes, vasculitis, and inflammatory bowel disease.  The range of the associations varied between 2·31(95% CI: 1·87-2·85) for systemic sclerosis to 3·71 (95% CI: 1·18-11·72) for Behçet’s disease. Guillain-Barré syndrome and type 1 diabetes (in the pediatric population) showed no evidence of association with SARS-CoV-2 infection.

Conclusion: Our results support a higher risk of developing at least 11 immune-mediated diseases after the acute phase (≥ 30 days) of SARS-CoV-2 infection. As autoimmunity has been identified as a hallmark of post-COVID-19 syndrome, an increase in the frequency of immune-mediated diseases is expected in the coming years. Healthcare professionals and stakeholders should be aware of these findings to prioritize research and public health surveillance. We thank the Colombian Association of Rheumatology (ASOREUMA) for their support. This work was supported by the Ministerio de Ciencia, Tecnología e Innovación de Colombia, MinCiencias, as part of the AGORA Project.(Contract No. 637-2022)

Supporting image 1

Figure 1: Study flow diagram summarizing the results of the literature search.

Supporting image 2

Table 1 Characteristics of the selected studies

Supporting image 3

Figure 2. Random effects meta-analysis of risk of new onset of immune-mediated diseases
after SARS-CoV_2 infection.


Disclosures: A. Gil: None; J. Barahona-Correa: None; J. Flórez-Suárez: None; D. Fernández-Ávila: None; Z. Cucunubá: None.

To cite this abstract in AMA style:

Gil A, Barahona-Correa J, Flórez-Suárez J, Fernández-Ávila D, Cucunubá Z. Risk of New Onset of Immune-Mediated Diseases After Sars-Cov-2 Infection: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/risk-of-new-onset-of-immune-mediated-diseases-after-sars-cov-2-infection-a-systematic-review-and-meta-analysis/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-new-onset-of-immune-mediated-diseases-after-sars-cov-2-infection-a-systematic-review-and-meta-analysis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology